524-35-6

Basic information

• Product Name: 7,9-DIMETHYLGUANINE
• Synonyms: HERBIPOLINE;2-AMINO-6,9-DIHYDRO-7,9-DIMETHYL-6-OXO-1H-PURIMIUM, INNER SALT;2-ammonium-6,9-dihydro-7,9-dimethyl-6-oxo-1H-purine;6-Oxylato-2-amino-7,9-dimethyl-9H-purin-7-ium;2-Amino-7,9-dimethyl-9H-purin-7-ium-6-olate
• CAS NO: 524-35-6
• Molecular Formula: C₇H₉N₅O
• Molecular Weight: 179.18
• EINECS: 208-356-0
• Product Categories: Nucleotides and Nucleosides;Nucleic acids;Bases & Related Reagents;Nucleotides
• Mol File: 524-35-6.mol

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: g/cm³
• Storage Temp.: 2-8°C(protect from light)
• Solubility: DMSO (Slightly, Heated, Sonicated), Methanol (Slightly, Heated, Sonicated)
• Stability: Hygroscopic
• CAS DataBase Reference: 7,9-DIMETHYLGUANINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7,9-DIMETHYLGUANINE(524-35-6)
• EPA Substance Registry System: 7,9-DIMETHYLGUANINE(524-35-6)

Safety Data

• Hazardous Substances Data: 524-35-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
7,9-Dimethylguanine is used as a lead compound for drug development due to its potential biological activities and involvement in the biosynthesis of marine natural products.
Used in Antimicrobial Applications:
7,9-Dimethylguanine is used as an antimicrobial agent for its ability to inhibit the growth of certain microorganisms, making it a potential candidate for the development of new antibiotics.
Used in Antiviral Applications:
7,9-Dimethylguanine is used as an antiviral agent for its potential to inhibit viral replication and infection, offering a promising avenue for the development of novel antiviral medications.

InChI:InChI=1/C7H9N5O/c1-11-3-12(2)5-4(11)6(13)10-7(8)9-5/h3H,1-2H3,(H2-,8,9,10,13)/p+1

Upstream product

• 77-78-1 dimethyl sulfate 
• 73-40-5 guanine 
• 7664-93-9 sulfuric acid 

Relevant articles and documents

METAL COMPLEXES OF N-HETEROCYCLIC CARBENES AS RADIOPHARMACEUTICALS AND ANTIBIOTICS

A method for inhibiting microbial growth comprises administering an effective amount of a silver complex of a N-heterocyclic amine. A method for treating cancer cells or a method for imaging one or more tissues of a patient includes administering an effective amount of a complex of a N-heterocyclic amine and a radioactive metal. N-heterocyclic carbenes of the present invention may be represented by formula (I) wherein Z is a heterocyclic group, and R1 and R2 are, independently or in combination, hydrogen or a C1-C12 organic group selected from the group consisting of alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, arylalkyl, alkylaryl, heterocyclic, and alkoxy groups and substituted derivatives thereof.